Transition report pursuant to Rule 13a-10 or 15d-10

EQUITY (Detail Narrative)

v3.22.1
EQUITY (Detail Narrative)
1 Months Ended 4 Months Ended 12 Months Ended
Feb. 15, 2022
shares
Mar. 05, 2021
$ / shares
shares
Feb. 12, 2021
$ / shares
shares
Jun. 19, 2020
shares
Dec. 06, 2019
USD ($)
$ / shares
shares
Dec. 02, 2019
shares
Jul. 21, 2021
$ / shares
shares
Nov. 30, 2020
$ / shares
shares
Aug. 17, 2018
shares
Dec. 31, 2021
USD ($)
integer
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Aug. 31, 2021
USD ($)
$ / shares
shares
Aug. 31, 2020
USD ($)
$ / shares
shares
Feb. 18, 2022
shares
Sep. 01, 2021
shares
Dec. 03, 2020
$ / shares
shares
Oct. 14, 2020
shares
Oct. 10, 2020
shares
Jan. 01, 2020
$ / shares
Common stock, par value (in dollars per share) | $ / shares                   $ 0.001 $ 0.001   $ 0.001     $ 0.001      
Common stock, shares authorized                   750,000,000 750,000,000   750,000,000     18,750,000,000      
Preferred stock, par value (in dollars per share) | $ / shares                   $ 0.001 $ 0.001 $ 0.001 $ 0.001            
Preferred stock, shares authorized                   6,250,000 6,250,000 6,250,000 6,250,000            
Preferred stock, shares outstanding                   0 0 0 0            
Preferred stock, shares issued                   0 0 0 0            
Common shares issued for settlement of debt | $                         $ 100,000            
Number of purchase common stock shares | integer                   10,120,000                  
Common stock shares issued during period                   17,774,310                  
Common stock, average price per share | $ / shares                   $ 1.06                  
Proceeds from commission and fees | $                   $ 18,262                  
Number of shares issued under options       425,000,000         375,000,000 748,738,000                  
Options exercisable description                 Options may be exercisable (“vest”) immediately or in increments based on time and/or performance criteria as determined by the administrator. The term of any option may not exceed 10 years (five years for any incentive stock option granted to a 10% stockholder), and unless otherwise determined by the administrator, each option must terminate no later than three months after the termination of the optionee’s employment (one year in the event of death or disability). Subject to a few minor exceptions, options may not be transferred other than by will or by the laws of descent and distribution.                    
Number of warrant granted                   10,120,000,000   10,120,000              
Expiration date under plan                 Aug. 17, 2028                    
Intrinsic value of the warrants | $                   $ 0   $ 338 $ 0            
Number of shares granted during period                   2,149,800,000   2,755,100 74,000,000            
Common shares issued for cash | $                   $ 18,262,000 $ 6,578,000 $ 8,103,000 $ 1,978,000            
Common stock, shares issued                   42,301,013   24,526,703 4,991,587            
Represents information of officer and director.                                      
Common shares issued for cash (in shares)                         45,834,000            
Valuation [Member]                                      
Options Granted                   2,149,800   2,755,100 74,000            
Option Granted, Value | $                   $ 1,170   $ 5,760 $ 190            
Stock option expense | $                   934   1,497 336            
Stock option expense, Related parties | $                   811   1,340 289            
Stock option expense, Unamortized | $                   4,489   4,263 409            
Stock option expense, Unamortized, Related parties | $                   $ 3,717   $ 3,664 $ 318            
Options Outstanding                   5,008,984   2,859,184 281,834            
Options Outstanding, intrinsic value | $                   $ 0   $ 37 $ 0            
Common Stock [Member]                                      
Common shares issued for settlement of debt | $                         $ 11,000            
Common stock shares issued during period                         7,373,000            
Common shares issued for cash (in shares)                         1,564,188,000            
Common shares issued for cash | $                         $ 1,978,000            
Common stock, shares issued                       19,535,116              
Expenses payable | $                   $ 6,579                  
Common stock , shares issued for exercise of warrants                   8,021,525                  
Proceeds from exercise of warrants | $                   $ 6,016                  
Offering costs | $                   $ 96     $ 1,923            
Common stock, shares issued during period                   1,393,591                  
Net proceeds | $                   $ 1,524                  
Average price | $ / shares                   $ 1.20                  
Commission fee | $                   $ 51                  
Gross sales price per share of common stock percentage                   3.00%     2.00%            
Number of issuance of common shares                         1,644,221,000            
Common shares issued for acquisition of license (in shares)                         61,297,000            
Common shares issued for settlement of debt (in shares)                         11,363,000            
Restricted Stock Awards [Member]                                      
Stock-based compensation expense | $                   $ 0 $ 14 $ 34 $ 42            
Director [Member]                                      
Common shares issued for cash | $                         $ 55,000            
Reversed expense | $                   $ 2                  
Number of cancelled common shares                         6,250,000            
Represents as a equity incentive plan. | Director [Member]                                      
Expiration date under plan         Dec. 06, 2029                            
Number of shares granted during period         10,000,000 22,250,000                          
Exercise price | $ / shares         $ 2.65                            
Stock option value | $         $ 24                            
Information about equity incentive plan. | Director [Member]                                      
Expiration date under plan         Dec. 06, 2029                            
Number of shares granted during period         40,000,000                            
Exercise price | $ / shares         $ 2.65                            
Stock option value | $         $ 98                            
2018 Equity Incentive Plan                                      
Common stock reserved for future issuance                   2,000,000       2,115,051 3,674,097        
Common stock, shares available to be issued                   2,213,851       4,586,554          
Common stock, shares issuable                   7,222,835                  
2018 Equity Incentive Plan | Subsequent Event [Member]                                      
Shares returned to option pool 257,652                                    
Common stock reserved for future issuance                           2,115,051          
Common stock, shares available to be issued                           4,586,554          
2018 Equity Incentive Plan | Employees Directors And Consultants [Member]                                      
Options granted                   794,800                  
Options granted exercise price | $ / shares                   $ 0.63                  
Options granted term                   ten (10) years                  
Options issued to non-employees vesting percentage                   33.00%                  
Options issued to non-employees vesting period                   24-month                  
Options issued to employees vesting period                   36-month                  
2018 Equity Incentive Plan | Principal Executive Officer [Member]                                      
Options granted                   1,355,000                  
Options granted exercise price | $ / shares                   $ 0.63                  
Options granted term                   ten (10) years                  
Options issued to non-employees vesting percentage                   25.00%                  
Options issued to non-employees vesting period                   24-month                  
Options issued to employees vesting period                   36-month                  
Options granted in fiscal year 2021 [Member]                                      
Options issued to non-employees vesting percentage   25.00% 50.00%                                
Exercise price | $ / shares   $ 1.52 $ 2.66       $ 1.00 $ 0.6035                      
Options granted to purchase shares of common stock   575,100 834,500       70,000                        
Options Granted               120,000                      
Options grant description               The Company anticipates the compensation to be $15 to $20 per year for the first year and $20 to $30 for the second year and thereafter, subject to formal approval by the Board.                      
Options granted in fiscal year 2021 [Member] | Options 2 [Member]                                      
Options issued to non-employees vesting percentage     25.00%                                
Exercise price | $ / shares     $ 2.66                                
Options granted to purchase shares of common stock     420,000                                
Options granted in fiscal year 2021 [Member] | Options 1 [Member]                                      
Options issued to non-employees vesting percentage     50.00%                                
Exercise price | $ / shares   $ 1.52 $ 2.66                                
Options granted to purchase shares of common stock   30,000 705,500                                
Options forfeited in fiscal year 2021 [Member]                                      
Unvested stock options             177,750                        
Vested stock options             23,750                        
Underwriting Agreement [Member] | Ladenburg Thalmann [Member] | Over-Allotment Option [Member]                                      
Number of warrants sold                                 1,320,000,000 1,320,000,000  
January 1, 2020 | Represents as a equity incentive plan.                                      
Expiration date under plan                   Dec. 13, 2029                  
Number of shares granted during period                   24,000                  
Exercise price | $ / shares                                     $ 2.12
Stock option value | $                   $ 68                  
Common shares issued for cash (in shares)                         1,518,354,000